Dalacin gel for external use 1% 30g

Indications and usage

Bacterial vaginosis

Contraindications

Hypersensitivity to Clindamycin, Lincomycin or any component of the drug.

Dosage and administration

A single dose (1 full applicator / 5 g of cream, approximately 100 mg of clindamycin / or 1 suppository) is inserted into the vagina before going to bed for 3 consecutive days. The cream can be administered for 7 consecutive days.

Suppositories can be administered without an applicator and with an applicator. After each use, the applicator should be washed with warm water and soap and dried well.

Adverse reactions

The incidence rate listed below is less than 10%.
From the reproductive system: irritation of the mucous membrane of the vulva and vagina, vaginal pain, vaginal discharge, vaginal candidiasis, vulvovaginitis, trichomonas vaginitis, vaginal infections, menstrual disorders, uterine bleeding, abnormal delivery, endometriosis.
On the part of the urinary system: dysuria, urinary tract infections (including pyelonephritis), proteinuria.
Gastrointestinal: generalized abdominal pain, localized abdominal pain, abdominal cramps, bloating, dyspepsia, nausea, vomiting, diarrhea, constipation, flatulence, bad breath, a perversion of taste.
From the side of the central nervous system: dizziness, headache.
Dermatological reactions: rash, itching, maculo-papular rash, erythema, skin candidiasis.
Allergic reactions: hives.
On the part of the endocrine system: glycosuria, hyperthyroidism.
On the part of the body as a whole: fungal infections, fever, pain in the side, back pain, lower abdominal pain, generalized pain, bacterial infections, inflammatory edema, upper respiratory tract infections, nasal bleeding, deviation of microbiological results from the norm.
Local reactions: itching and pain at the injection site.

Special notes

Before prescribing the drug with the help of special laboratory methods, the following possible causative agents of vulvovaginitis should be excluded: Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, Candida albicans and Herpes simplex virus.

Intravaginal administration of Dalacin can lead to increased growth of microorganisms insensitive to the preparation, especially yeast-like fungi.

With systemic use of clindamycin (like almost all antibiotics), severe diarrhea and, in some cases, pseudomembranous colitis may develop. In this regard, when severe or long-term diarrhea occurs during Dalacin therapy, the drug should be discontinued and, if necessary, diagnostic and therapeutic measures should be taken.

The combined use of the drug Dalacin with other drugs for intravaginal administration is not recommended.

The patient should be informed that during the use of vaginal cream and vaginal suppositories, sexual contact should be avoided, as well as the use of other types of products intended for intravaginal administration (for example, tampons, douching).

Dalacin in the form of vaginal suppositories and vaginal cream contains components that can reduce the strength of latex or rubber products (condoms, vaginal contraceptive contraceptives). Therefore, the use of such products during treatment with Dalacin in the form of vaginal suppositories and vaginal cream is not recommended.

Keep out of reach of children at a temperature not exceeding 25 ° C. Do not freeze.